Breast Cancer Survivors Who Take Aspirin Have 50% Reduced Risk Of Metastasis
Economic Analysis Finds Erlotinib Marginally Cost-Effective For NSCLC
Racial Disparities Persist In Diagnosis Of Advanced Breast Cancer, Colon Cancer
Breast Cancer Rates Decline Most for Affluent White Women
Low Prevalence Of Tamoxifen Use For Cancer Prevention
Symptoms Don’t Help Detect Early-Stage Ovarian Cancer
Two-Week Break Balances RT Palliation, Side Effects
NCI Cooperative Group Clinical Trials Approved
Trending Stories
- OMB proposed rule could end 50% of currently active clinical trials, Stand up for Science analysis finds
- What NHS-Galleri taught us—and what it didn’t
- The NHS-Galleri trial has and will continue to provide critical insights to refine future MCED studies
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- The Directors: Directors of two Midwestern cancer centers tell us about the challenging healthcare economics in rural areas
“Institutions are feeling crunched in so many different directions” - Ian Krop named section chief of Medical Oncology and Hematology and deputy director for Clinical Affairs at Yale









